跳至主要内容
临床试验/JPRN-UMIN000003723
JPRN-UMIN000003723招募中未知

Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patients - influence of polymorphisms of drug metabolizing enzymes and transporters on Docetaxel Pharmacokinetics

Research institute for diseases of the chest, Kyushu University0 个研究点目标入组 50 人开始时间: 2010年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)History of poorly controlled pleural effusion, pericardial effusion and ascites. 2)Active infection 3)Previous severe drug allergy 4)Hoped to be pregnant/nursing. 5)Symptomatic brain metastasis 6)Active concomitant malignancy 7)History of poorly controlled diabetes mellitus 8)History of severe complicating disease 9)simultaneous use of other anti-cancer drugs 10)Those judged to be not suitable by the attending physician 11)History of bone-marrow transplantation 12)Those who received a white blood cell transfusion within 30 days before registration

研究者

发起方
Research institute for diseases of the chest, Kyushu University

相似试验